LEO Pharma is a global pharmaceutical company dedicated to improving the lives of people with skin diseases and rare genetic disorders. With a focus on dermatology and critical care, LEO Pharma develops innovative treatments and therapies to address unmet medical needs in these areas. The company's commitment to research and development, along with its patient-centric approach, sets it apart in the orphan drug and rare disease space. LEO Pharma's presence at World Orphan Drug Congress USA 2026 demonstrates its dedication to advancing the field and collaborating with stakeholders to make a meaningful impact on patients' lives.